VENASEAL: A GOOD SOLUTION IN THE TREATMENT OF SEVERE SUPERFICIAL VENOUS INSUFFICIENCY IN VERY ELDERLY PATIENTS

Authors

  • Marta Machado CUF Viseu; Luz Arrábida; Hospital de Riba de Ave, Portugal
  • Miguel Machado CUF Viseu; Luz Arrábida; Hospital de Riba de Ave, Portugal
  • Arlindo Matos CUF Viseu; Luz Arrábida; Hospital de Riba de Ave; Centro Hospitalar Universitário do Porto, Portugal
  • Rui Machado CUF Viseu; Luz Arrábida; Hospital de Riba de Ave; Centro Hospitalar Universitário do Porto, Portugal

DOI:

https://doi.org/10.48750/acv.409

Keywords:

venaseal, eldery, Venous cronic disease, Varicose veins

Abstract

Introduction: Chronic venous disease is a prevalent condition that worsens with age and is associated with poor quality of life.
The treatment of varicose veins (VV) has multiple alternatives, and different practices across Europe.
The aim of this article is to analyze the treatment of very elderly patients with severe forms of chronic venous disease using the VenaSeal technique.

Method, Material and Results: Report of 5 very old patients with severe venous insufficiency treated with Vena- Seal in 2021.

Clinical case 1: A 86-year-old woman, with untreated bilateral varicose veins and recurrent ulcers, was observed in consultation, complaining of severe pain in left leg with an doppler ultrasound (DUS) showing bilateral great saphenous vein (GSV) insufficiency.
An outpatient basis treatment of the left great saphenous vein with VenaSeal associated with phlebectomies was performed in the left side.

After 6 months of follow-up, she is asymptomatic with small areas of repermeabilization of the proximal trunk of GSV.

Clinical case 2: A 85-year-old man was observed in consultation describing two episodes of varicorrhagia in his right leg and and DUS with bilateral great saphenous vein insufficiency.
An outpatient basis treatment of the right great saphenous vein with VenaSeal associated with varicose veins foam esclerotherapy DUS guided was performed.

After a 3-month follow-up, the patient is asymptomatic with the imaging control showing occlusion of the trunk of the great saphenous vein.

Clinical case 3: A 97-year-old woman was observed in consultation complaining of severe pain in left leg associated with an ulcer with severe interference with her quality of life and a DUS with bilateral great saphenous vein insufficiency. An outpatient basis treatment of the left great saphenous vein with VenaSeal associated with varicose veins foam esclerotherapy DUS guided was performed.

After a 2-month follow-up, the patient is asymptomatic with a healed ulcer, with the DUS control showing occlusion of the great saphenous trunk.

Clinical case 4: A 95-year-old woman was observed in consultation describing bilateral severe pain and ulcers in both legs and DUS with bilateral great saphenous vein insufficiency.
An outpatient basis treatment of bilateral great saphenous vein with VenaSeal associated with varicose veins foam esclerotherapy DUS guided was performed.

After 1-month follow-up, she is asymptomatic with healed ulcers and has occlusion of the right GSV ́s trunk and areas of repermeabilization of left GSV ́s trunk.

Clinical case 5: An 84-year-old woman was observed in consultation with severe pain and severe pruritus of the left leg and a DUS with left GSV insufficiency.
An outpatient basis treatment of the left GSV with VenaSeal associated with phlebectomies was performed.
After 1 month of follow-up, the patient is asymptomatic with occlusion of the proximal left GSV ́s trunk.

Discussion/Conclusion: Treatment with Venaseal is not considered in the 2015 Guidelines of the ESVS, however the VeClose Study compared VenaSeal with radiofrequency ablation and reported equivalent improvement in symptoms scores and GSV occlusion.
VenaSeal treatment doesn ́t require use of elastic compression after surgery and allows return to routine activity immediately, so it may be a good therapeutic option in this age group of patients with high clinical risk.

In our experience, VenaSeal resulted in complete resolution of the symptoms and ulcers in the short term. However, a complete occlusion of GSV was not observed in all cases, so new studies and protocols doses can be necessary.

Downloads

Download data is not yet available.

References

1. The Seriousness of Chronic Venous Disease: A Review of Real- World Evidence Alun H. Davies Adv Ther (2019) 36: S5–S12
2. Carradice D, Mazari FA, Samuel N, Allgar V, Hatfield J, Chetter IC. Modelling the effect of venous disease on quality of life. Br J Surg. 2011;98(8):1089–98
3. Moore HM, Lane TR, Thapar A, Franklin IJ, Davies AH. The European burden of primary varicose veins. Phlebology. 2013;28(Suppl 1):141–7
4. Wittens et al. Management of Chronic Venous Disease Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS) Eur J Vasc Endovasc Surg (2015) 49, 678 e 737 C.
5. K, Morikage N, Yamashita O, et al. Adherence to and efficacy of different compression methods for treating chronic venous insufficiency in the elderly. Phlebology. 2016;31(10):723-728
6. Morrison, N.; Gibson, K.; Vasquez, M.; Weiss, R.; Cher, D.; Madsen, M.; Jones, A. VeClose trial 12-month outcomes of cyanoacrylate closure versus radiofrequency ablation for incompetent great saphenous veins. J. Vasc. Surg. Venous Lymphat. Disord. 2017, 5, 321–330.
7. Proebstle T., Alm J et al. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2015 Jan;3(1):2-7.
8. Kathleen Gibson, Renee Minjarez, Krissa Gunderson, Brian Ferris. Need for adjunctive procedures following cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of postprocedure compression: Three-month data from a postmarket evaluation of the VenaSeal System (the WAVES Study). Volume: 34 issue: 4, page(s): 231-237; May 1, 2019
9. Proebstle, T.M.; Alm, J.; Dimitri, S.; Rasmussen, L.; Whiteley, M.; Lawson, J.; Cher, D.; Davies, A. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphe- nous veins. J. Vasc. Surg. Venous Lymphat. Disord. 2015, 3, 2–7.
10. Park, I et al. Initial Outcomes of Cyanoacrylate Closure, Vena- Seal System, for the Treatment of the Incompetent Great and Small Saphenous Veins. Vasc. Endovasc. Surg. 2017, 51, 545–54
11. Kathleen Gibson, Renee Minjarez, Elena Rinehardt, Brian Ferris. Frequency and severity of hypersensitivity reactions in patients after VenaSealTM cyanoacrylate treatment of superficial venous insuf- ficiency. Article information. Volume: 35 issue: 5, page(s): 337-344.
12. Insoo Park, MD1, Daehwan Kim, MD1. Correlation Between the Immediate Remnant Stump Length and Vein Diameter After Cyanoacrylate Closure Using the VenaSeal System During Treatment of an Incompetent Great Saphenous Vein. Article information. Volume: 54 issue: 1, page(s): 47-50 January 1, 2020.

Additional Files

Published

2021-12-24

Issue

Section

Original Article